Ethanol, Acetaldehyde, and Estradiol Affect Growth and Differentiation of Rhesus Monkey Embryonic Stem Cells

California National Primate Research Center, Davis, CA 95616, USA.
Alcoholism Clinical and Experimental Research (Impact Factor: 3.21). 03/2011; 35(8):1534-40. DOI: 10.1111/j.1530-0277.2011.01490.x
Source: PubMed

ABSTRACT The timing of the origins of fetal alcohol syndrome has been difficult to determine, in part because of the challenge associated with in vivo studies of the peri-implantation stage of embryonic development. Because embryonic stem cells (ESCs) are derived from blastocyst stage embryos, they are used as a model for early embryo development.
Rhesus monkey ESC lines (ORMES-6 and ORMES-7) were treated with 0, 0.01, 0.1, or 1.0% ethanol, 1.0% ethanol with estradiol, or 0.00025% acetaldehyde with or without estradiol for 4 weeks.
Although control ESCs remained unchanged, abnormal morphology of ESCs in the ethanol and acetaldehyde treatment groups was observed before 2 weeks of treatment. Immunofluorescence staining of key pluripotency markers (TRA-1-81 and alkaline phosphatase) indicated a loss of ESC pluripotency in the 1.0% ethanol group. ORMES-7 was more sensitive to effects of ethanol than ORMES-6.
Estradiol appeared to increase sensitivity to ethanol in the ORMES-6 and ORMES-7 cell line. The morphological changes and labeling for pluripotency, proliferation, and apoptosis demonstrated that how ethanol affects these early cells that develop in culture, their differentiation state in particular. The effects of ethanol may be mediated in part through metabolic pathways regulating acetaldehyde formation, and while potentially accentuated by estradiol in some individuals, how remains to be determined.

Download full-text


Available from: Catherine A Vandevoort, Sep 28, 2015
26 Reads
  • Source
    • "Rhesus monkey ESCs (rESCs) have become an important tool used in molecular biology research. They can be used to explore complicated disease mechanisms in vitro [25, 26] and can also be used in transplantation studies to model diseases in situ [3]. One of the great advantages of rhesus monkey ESCs is that they share many characteristics with human ESCs, including cellular morphology, surface marker expression, and developmental potential [10], as well as greater than 90% DNA homology [27–30], which allows for better mimicry of the human system. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The rhesus monkey embryonic stem cell line R366.4 has been identified to differentiate into a number of cell types. However, it has not been well characterized for its response to drugs affecting reproductive endocrinology. Kisspeptins (KPs) are ligands for the GPR-54, which is known to modulate reproductive function. The current study was designed to determine the effect of the KP-10 peptide on R366.4 cells and to investigate the role of KP-GPR54 in the cell proliferation process. Four different doses (0.1, 1, 10, and 100 nM) of KP-10 and control were selected to evaluate cell growth parameters and cellular morphological changes over a 72 hr period. The cells were treated with kisspeptin-10 during the early rosette stage. Proliferation rates, analyzed by flow cytometry and cell count methods, were found to be decreased after treatment. Moreover, the number of rosettes was found to decrease following KP-10 treatments. Morphological changes consisting of neuronal projections were also witnessed. This suggested that KP-10 had an antiproliferative effect on R366.4 cells leading to a differentiation state and morphological changes consistent with neuronal stem cell development. The R366.4 stem cell line differentiates based on kisspeptin signaling and may be used to investigate reproductive cell endocrinology in vitro.
    The Scientific World Journal 11/2013; 2013:135470. DOI:10.1155/2013/135470 · 1.73 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The transcription factors Sox2, Oct4 and Nanog, regulate within a narrow dose range embryonic stem (ES) cell pluripotency and cell lineage commitment. Excess of Oct4 relative to Sox2 guides cells to mesoendoderm (ME), while abundance of Sox2 promotes neuroectoderm (NE) formation. Literature does not address whether ethanol interferes with these regulatory interactions during neural development. We hypothesized that ethanol exposure of ES cells in early differentiation causes an imbalance of Oct4 and Sox2 that diverts cells away from NE to ME lineage, consistent with teratogenesis effects caused by prenatal alcohol exposure. Mouse ES cells were exposed to ethanol (0, 25, 50, 100 mM) during retinoic acid (10 nM)-directed differentiation to NE for 0-6 days, and the expression of Sox2, Oct4 and Nanog was measured in single live cells by multiparametric flow cytometry, and cellular phenotype was characterized by immunocytochemistry. Our data showed an ethanol dose- and time-dependent asymmetric modulation of Oct4 and Sox2 expression, as early as after 2 days of exposure. Single cell analysis of the correlated expression of Sox2, Oct4 and Nanog revealed that ethanol promoted distinct subpopulations with high Oct4/Sox2 ratio. Ethanol-exposed cells differentiated to fewer β-III tubulin immunoreactive cells with an immature neuronal phenotype by 4 days. We interpret these data as suggesting that ethanol diverted cells in early differentiation from NE fate towards ME lineage. Our results provide a novel insight into the mode of ethanol action and opportunities for discovery of prenatal biomarkers at early stages.
    Stem cells and development 03/2013; 22(15). DOI:10.1089/scd.2012.0513 · 3.73 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ethanol consumption during pregnancy is a widespread problem and is increasing globally among young women. Development of biomarkers of fetal alcohol syndrome (FAS), which can identify children at risk, may lead to interventions earlier in life. In addition, animal models of fetal alcohol spectrum disorders can help in novel biomarker discovery. Biomarkers of fetal alcohol spectrum disorders include classical biomarkers of alcohol-induced pathology (mean corpuscular volume, γ-glutamyl transferase, aspartate aminotransferase, and alanine aminotransferase), acetaldehyde-derived conjugates, and derivatives of nonoxidative ethanol metabolism (fatty acid ethyl esters, ethyl glucuronide, ethyl sulfate, and phosphatidyl ethanol). Because ethanol and acetaldehyde levels can be measured in blood, urine, and sweat a few hours after ethanol intake, these can be used to detect recent ethanol exposure. Magnetic resonance spectroscopic (MRS) biomarkers include N-acetyl aspartate, an indicator of neuronal density; choline, a precursor of the neurotransmitter; acetyl choline, implicated in learning and memory and in the synthesis of glycerophosphocholine (involved in membrane synthesis); and glutamate that is reduced in FAS. Glutamate is a precursor for the synthesis of γ-amino butyric acid, and creatine is required for high-energy phosphate synthesis. Furthermore, reduced brain-derived neurotropic factor, somatostatin, complexin, taurine, glutathione, myoinositol, leptin, and increased insulin-like growth factor and N-methyl D-aspartic acid receptor toxicity are observed in FAS. Impaired methionine–homocysteine cycle may also have deleterious effects on protein, DNA, and histone methylation in FAS. In addition to meconium fatty acid ethyl esters, magnetic resonance imaging, positron emission tomography, and single-photon-emission computerized tomography facilitate an earlier diagnosis of less alcohol-related disabilities that cannot be confirmed in the absence of a maternal drinking history. Brain volume, cortical volume, and cortical surface area are also reduced following prenatal exposure to ethanol. Hence, discovery of novel biomarkers is needed to define behavioral, physical, and genetic factors for better clinical management of FAS.
    Biomarkers and Genomic Medicine 03/2014; DOI:10.1016/j.bgm.2014.01.002
Show more